| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-14 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-11 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |